GlobalRPh Clinical TechnologyBeyond LDL-C: Understanding Cardiovascular Risk With PREVENT, ApoB, Lp(a), Non-HDL-C and Advanced Lipid AnalysisIntroducing the GlobalRPh Cardiovascular Risk and Advanced Lipid Analyzer, a layered cardiovascular prevention tool that combines the standard lipid panel with advanced lipoprotein markers, derived calculations, kidney and metabolic context, coronary calcium, and the American
Frailty Before the ICU: Using Frailty Scores to Guide Escalation Without Turning Them Into Gatekeepers
Frailty Before the ICU: Using Frailty Scores to Guide Escalation Without Turning Them Into Gatekeepers Review Abstract Purpose: Frailty has emerged as an important predictor of adverse outcomes in hospitalized and critically ill adults, particularly among older patients with multiple chronic conditions. As healthcare systems increasingly care
Melanoma Screening in the AI Era: Why Dermatologists Remain the Clinical Standard and AI Should Stay an Adjunct
Melanoma Screening in the AI Era: Why Dermatologists Remain the Clinical Standard and AI Should Stay an Adjunct Review Abstract Purpose: Melanoma remains one of the most aggressive forms of skin cancer, accounting for a disproportionate number of skin cancer related deaths despite representing a relatively small
Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup
Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup Review Abstract Purpose: Resistant hypertension remains a significant clinical challenge and is associated with a markedly increased risk of cardiovascular disease, chronic kidney disease progression, stroke, heart failure, and premature mortality. Despite the availability of multiple
Vaccines and Catch-Up in 2026: Schedule Navigation, Documentation, and Vaccine Confidence for Clinicians
Vaccines and Catch-Up in 2026: Schedule Navigation, Documentation, and Vaccine Confidence for Clinicians Review Abstract Purpose: This review provides a comprehensive overview of contemporary vaccine practice in 2026, with emphasis on immunization schedule navigation, catch up vaccination, documentation standards, vaccine safety, product specific recommendations, and evidence based communication
Vestibular Migraine in Neurology Clinics: The Great Mimicker Behind Recurrent Vertigo
Vestibular Migraine in Neurology Clinics The Great Mimicker Behind Recurrent Vertigo Review Abstract Purpose: Vestibular migraine is increasingly recognized as one of the most common neurological causes of recurrent episodic vertigo and dizziness, yet it remains substantially underdiagnosed and frequently misclassified in routine clinical practice. Patients
Quantitative Neuromuscular Monitoring: Why Are We Still Guessing at Recovery?
Quantitative Neuromuscular Monitoring Why Are We Still Guessing at Recovery Review Abstract Purpose: This review critically evaluates the scientific rationale, current evidence, professional guideline recommendations, and practical implementation of quantitative neuromuscular monitoring during recovery from neuromuscular blockade, with particular emphasis on patients receiving nondepolarizing neuromuscular blocking
BTK Degraders in CLL/SLL After BTK Inhibitor Failure: A Promising Escape Route Still Under Study
BTK Degraders in CLL/SLL After BTK Inhibitor Failure: A Promising Escape Route Still Under Study Review Abstract Purpose: This review assesses the rationale, emerging clinical evidence, safety considerations, and practical implications of Bruton tyrosine kinase (BTK) degraders in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), particularly after
AI Surgical Coaches: Do They Improve Outcomes, or Just Performance Metrics? What Early Real-World Data Show
AI Surgical Coaches: Do They Improve Outcomes, or Just Performance Metrics? What Early Real-World Data Show Review Abstract Purpose: This review examines the emerging evidence for artificial intelligence-assisted surgical coaching, with particular emphasis on whether these systems improve clinically meaningful outcomes or primarily improve technical-performance and
Can Bispecific Antibodies Move Safely Into the Outpatient Clinic? A Label-Concordant Framework for Clinicians
Can Bispecific Antibodies Move Safely Into the Outpatient Clinic? A Label-Concordant Framework for Clinicians Review Abstract Purpose: This review assesses whether CD3-engaging bispecific antibody therapy can be delivered safely in outpatient oncology settings, with emphasis on cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, infection prevention,
